Parkinson's Disease Trial, Recruiting NCT06906679 Sponsor: IRCCS San Raffaele Roma Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06906679
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 30 and 80 years old
  • You have been diagnosed with Parkinson's disease using a specific set of standard medical guidelines (confirm with trial site)
  • Your Parkinson's symptoms are at a moderate stage, rated between 2 and 3 on a standard scale when your medication is working well (confirm with trial site)
  • You scored 17.54 or above on a standard memory and thinking test called the MoCA (confirm with trial site)
  • Your Parkinson's medication has stayed the same for at least 4 weeks before the trial and would remain unchanged throughout it
  • You are able to understand the study and sign a consent form agreeing to take part
  • You have already signed the consent form to participate in the study
  • You are able to follow and take part in all the study procedures as required

Who may not be able to join:

  • You are unwilling or unable to stick to the exercise programme required by the trial
  • You have another brain or nervous system condition alongside Parkinson's disease, or have been diagnosed with a psychiatric condition or personality disorder
  • You have a bone, joint, or muscle condition that affects the movement of your arms or hands
  • You have not signed the required consent form to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prof. Marco Franceschini, MD, IRCCS San Raffaele Roma

Phone: +39 0652252405

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele Roma
Registry
ClinicalTrials.gov
Start date
20 December 2023
Est. completion
20 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Box and Block Test (BBT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov